Brandinium

Trademark search for:

THALIDOMIDE CELGENE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2017-01-20 — Application filed
  • 2017-02-01 — Application filed
  • 2017-02-01 — Application filed
  • 2017-02-16 — Teas voluntary amendment received
  • 2017-03-02 — Assigned to lie
  • 2017-03-08 — Preliminary/voluntary amendment - entered
  • 2017-04-14 — Assigned to examiner
  • 2017-04-18 — Final disposition recorded
  • 2017-04-18 — Final disposition recorded
  • 2017-04-18 — Final disposition recorded
  • 2017-04-19 — Office action issued
  • 2017-04-27 — Correspondence received in law office
  • 2017-04-27 — Teas/email correspondence entered
  • 2017-04-27 — Approved for pub - principal register
  • 2017-05-05 — Law office publication review completed
  • 2017-05-24 — Notification of notice of publication e-mailed
  • 2017-06-13 — Published for opposition
  • 2017-06-13 — Official gazette publication confirmation e-mailed
  • 2017-08-29 — Registered-principal register
  • 2022-08-29 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2022-12-09 — Teas withdrawal of attorney received-firm retains
  • 2022-12-09 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-12-09 — Attorney/dom.rep.revoked and/or appointed
  • 2022-12-09 — Teas change of correspondence received
  • 2022-12-09 — Applicant/correspondence changes (non-responsive) entered
  • 2022-12-09 — Teas change of owner address received
  • 2024-03-15 — Cancelled sec. 8 (6-yr)
  • 2024-03-15 — Final status recorded

Owner Information

Celgene Corporation
Summit , NJ
Celgene Corporation
Summit , NJ
Celgene Corporation
Summit , NJ

Correspondent

Marilyn F. Kelly Bristol-Myers Squibb Company
PO BOX 4000
Trademark Dept., Mailstop D.4243
PRINCETON, NJ 08648

Filing Details

Filing Date:
2017-01-20
Status Date:
2024-03-15
Category:
Pharmaceuticals
Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.